We are live on ! Find out more
IBER.U

Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U

Delisted

IBER.U was delisted on the 1st of March, 2023.

Back to rankings

60 hedge funds and large institutions have $121M invested in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in 2021 Q1 according to their latest regulatory filings, with 60 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
+60
Holders Change %
–
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
60
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HP
Hartree Partners
New York
+$12.8M
2
MF
Magnetar Financial
Illinois
+$8.03M
3
Citadel Advisors
Citadel Advisors
Florida
+$7.75M
4
Millennium Management
Millennium Management
New York
+$5.25M
5
PAMP
Polar Asset Management Partners
Ontario, Canada
+$5M

Top Sellers

No sellers this quarter

IBER.U Hedge Fund Activity: Q1 2021 in Review

60 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) for Q1 2021, worth a combined $121M.

Buyers outnumbered sellers: 60 funds opened new IBER.U positions and 0 closed out — a net gain of 60 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Hartree Partners, opening a new position worth an estimated $12.8M.

  • 60 institutional investors held Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $121M of Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant stock for Q1 2021.
  • 60 funds opened new Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant positions in Q1 2021 and 0 closed out, a net change of +60 holders.
  • The largest Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant buyer in Q1 2021 was Hartree Partners, an estimated $12.8M added.

Based on aggregated 13F filings for Q1 2021.